Amprenavir: A Viewpoint by Graeme Moyle

By Moyle G.  

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 843-844

Adis International

Access to resources Recommend Favorite

Pharmacology and clinical experience with amprenavir

By Conway B.   Shafran S.D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 371-382

Informa Healthcare

Access to resources Recommend Favorite

Fosamprenavir: Clinical Pharmacokinetics and Drug Interactions of the Amprenavir Prodrug

By Mary Beth Wire  

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 137-168

Adis International

Access to resources Recommend Favorite

Amprenavir/lamivudine/ritonavir/stavudine: Graves' disease (first report with amprenavir) leading to hyperthyroidism: case report

By  

Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Amprenavir/didanosine/stavudine: Acanthosis nigricans in a child (first report with amprenavir): case report

By  

Reactions Weekly, Vol. 1, Iss. 1084, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite